european prostate cancer therapeutics market “the european market for prostate cancer therapeutics...

European Prostate Cancer Therapeutics Market

“The European Market for Prostate Cancer Therapeutics is largely underdeveloped. It is

constantly changing, offering industry participants many new market

opportunities.”

Key features

• Quality Analysis of the European LHRH and Anti-Androgen Therapeutics Market

• The most in depth Analysis available of the European Brachytherapy Seeds Market

• Coverage of Emerging Therapies• Strong Focus on Market Challenges & Strategies

VOICE OVER TIPS

• make sure the bullet points stand up on their own• raise the most salient points and talk knowledgably around

each one!• Target time 30 - 40 seconds

Key content: Revenue Forecasts & Competitive Analysis

Total Prostate Cancer Therapeutics Market: Revenue Forecasts (Europe), 1998 - 2008

0

200

400

600

800

1000

1200

1400

1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008

Year

Re

ve

nu

es ($m

)

Market Size and Forecast

Segmentation: LHRH Analogs, Anti-Androgens Brachytherapy Seeds

Market Share Analysis- European & Country Levels

Featured Companies

• AstraZeneca• Takeda• Ipsen Biotech• Schering Ag• Amersham Health

What to do next

For more informationCall 44 20 7343 8342 or

emailenquiries@fs-europe.com

Prostate Cancer Therapeutics is part of the Global Oncology

Subscription www.pharma.frost.com